))
Samsung could join Apple in non-invasive glucose monitor battle
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on October 11, 2024 03:40 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 397348754 series 3481361
Контент предоставлен Fast Five by MassDevice. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Fast Five by MassDevice или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, January 24, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Cognito Therapeutics has enrolled its first patients in a sensory neurostim biomarker study. Fast Five hosts Sean Whooley and Danielle Kirsh discuss what the trial will look like and how executives see this transforming treatment option. The UK NHS Trust treated the first patients with Allurion's weight loss balloon. Learn more about the technology and the results from the first treatments. A former Boston Scientific executive joined the board of directors of pulsed field ablation company Mirai Medical. Whooley talks about their career history and what Mirai Medical is doing. Earnings season is upon us, and Johnson & Johnson MedTech has reported a 13% sales uptick in Q4. Hear more updates from the Abiomed acquisition and how the company's electrophysiology portfolio is doing. A new report claims that Samsung is joining Apple in the non-invasive glucose monitor battle. The Fast Five hosts talk about the implications this could have on the glucose monitoring market and if there's a projected timeline. BONUS: How does medtech CEO compensation compare? Read more about the pay dynamics of the medical device industry.
…
continue reading
161 эпизодов
Поделиться
